|
| |
neopharm illinois Pages on BioPortfolio:
BioPortfolio - NeoPharm - Profile
Research and Development, NeoPharm Inc., Waukegan, Illinois 60085, USA. .... NeoPharm Signs IL-13 Related CRADA with NINDS/ NIH for Research on the ...
http://www.bioportfolio.com/biocorporate/7437-NeoPharm.pdf...
|
Biotechnology News Neopharm besudotox. cintredekin. il13. pe38qqr ...
Current Search: neopharm: 9, besudotox: 3, cintredekin: 3, il13: 3, pe38qqr: 3, ... Leica has released a new microscope, the DM IL LED, the first inverted ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - NeoPharm
Research and Development, NeoPharm Inc., Waukegan, Illinois 60085, USA. Anticancer Drugs. 2006 Jan;17(1):53-61. A novel cationic cardiolipin analogue
for ...
http://www.bioportfolio.com/biocorporate/7437-NeoPharm.html...
|
Biotechnology News Neopharm Search
NeoPharm Signs IL-13 Related CRADA with NINDS/ NIH for Research on the Therapeutic Agent for Untreatable Brain - NeoPharm, Inc. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
BioPortfolio - NeoPharm
neopharm illinois - BioPortfolio. ... neoPharm waukegan il BioPortfolio NeoPharm was founded in 1990 under the name OncoMed Inc and changed its name to . ...
http://www.bioportfolio.com/search/NeoPharm.html...
|
BioPortfolio.com - BioWeb Glioblastoma Search
Triangle Park, NC hypericin Nexell Therapeutics glioblastoma multiforme in clinical trials Irvine, CA (949) 470- 9011 IL 13- PE38QQR Neopharm malignant ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
BioPortfolio - neopharm location
NeoPharm Signs IL-13 Related CRADA with National Institute Of ... 15 Oct 2008 .. . LAKE BLUFF, Ill.--(BUSINESS WIRE)--NeoPharm, Inc. (NASDAQ: NEOL), ...
http://www.bioportfolio.com/search/neopharm_location.html...
|
BioPortfolio.com - BioWeb Esophageal Motility Search
Neopharm Complete a new search Drug Name (Proprietary name/Generic name) ... Ovarian Carcinoma Neopharm Lake Forest, IL Phase I/II - IL 13-PE38QQR none / IL
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
BioPortfolio - MDS Neopharm
Triangle Park, NC IL 13- PE38QQR Neopharm malignant glioma Phase I/ II Bannockburn, ... MD meningioma N C I TR I A L AstraZeneca (800) 4- CANCER ...
http://www.bioportfolio.com/search/MDS_Neopharm.html...
|
BioPortfolio.com - BioWeb TAXOTERE DOCETAXEL genentechidec ...
... pancreatic, prostate, skin, stomach, other) SS1( dsFv)- PE38 NeoPharm esophageal cancer, nasopharyn- in clinical trials Bannockburn, IL geal cancer .
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...
|
Results from other life science and pharmaceutical sites:
BioPortfolio - NeoPharm - Profile
Research and Development, NeoPharm Inc., Waukegan, Illinois 60085, USA. .... NeoPharm Signs IL-13 Related CRADA with NINDS/ NIH for Research on the ...
http://www.bioportfolio.com/biocorporate/7437-NeoPharm.pdf...
|
NeoPharm Signs IL-13 Related CRADA with NINDS/ NIH for Research on ...
NeoPharm Signs IL-13 Related CRADA with NINDS/ NIH for Research on the Therapeutic Agent for Untreatable Brain Diseases. - LAKE BLUFF, Ill.--(BUSINESS
...
http://biz.yahoo.com/bw/081015/20081015005408.html?.v=1...
|
BioPortfolio - NeoPharm
Research and Development, NeoPharm Inc., Waukegan, Illinois 60085, USA. Anticancer Drugs. 2006 Jan;17(1):53-61. A novel cationic cardiolipin analogue
for ...
http://www.bioportfolio.com/biocorporate/7437-NeoPharm.html...
|
BioSpace - NeoPharm News, Search Jobs, Events
NeoPharm Inc. 100 Corporate North, Suite 215 Bannockburn Illinois 60015 U.S.A. Phone: 847-295-8678-Ext-115 Fax: 847-295-8854 ...
http://www.biospace.com/company_profile.aspx?CompanyId=2445...
|
NEOL: Profile for NeoPharm, Inc. - Yahoo! Finance
NeoPharm was founded in 1990 under the name OncoMed, Inc. and changed its name to NeoPharm, Inc. in 1995. The company is based in Waukegan, Illinois. ...
http://biz.yahoo.com/p/N/NEOL.html...
|
NeoPharm Announces Execution of a Letter of Intent with SIRO ...
"We welcome the opportunity to help NeoPharm conduct this complex oncology trial in India, where we believe IL-13 will be most likely to demonstrate ...
http://www.biospace.com/news_story.aspx?NewsEntityId=97539...
|
NeoPharm to Launch New Transfection Agent Using Novel Cationic ...
Cationic cardiolipin and NeoPhectin(TM) are proprietary products developed by NeoPharm at its Waukegan, Illinois research and development facility. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
NeoPharm, Inc. Announces Second Quarter 2008 Financial Results ...
NeoPharm, Inc., based in Lake Bluff, Illinois, is a publicly traded biopharmaceutical company dedicated to the research, development and
commercialization ...
http://biz.yahoo.com/bw/080814/20080814006027.html?.v=1...
|
NeoPharm Signs First Worldwide NeoPhectin(TM) Distribution and ...
Both NeoPhectin(TM) and NeoPhectin-AT(TM) were developed by NeoPharm at the Company's Waukegan, Illinois research and development facility. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Technology evaluation: Cintredekin besudotox, NeoPharm /Nippon ...
program. NeoPharm Inc PRESS RELEASE 2004 February 06. 526592 NeoPharm's IL-13- PE38QQR enters phase III for glioma. NeoPharm Inc PRESS RELEASE 2004 March 08
...
http://www.biomedcentral.com/content/pdf/cd-592033.pdf...
|
|
